Adverse Dermatologic Reactions in Patients Treated With Immune Checkpoint Inhibitors

被引：0
|
作者：
Gregori, R. Fayos [1 ]
Hoyos, C. Labrandero [2 ]
Leal, R. Penuelas [2 ]
Miquel, V. Alegre de [1 ,2 ]
机构：
[1] Univ Valencia, Fac Med, Valencia, Spain
[2] Hosp Gen Univ Valencia, Serv Dermatol, Valencia, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 03期
关键词：
EVENTS; ASSOCIATION; PD-1;
D O I：
10.1016/j.ad.2022.08.019
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [41] Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors
    Suijkerbuijk, Karijn P. M.
    Kapiteijn, Ellen
    Verheijden, Rik J.
    JAMA ONCOLOGY, 2020, 6 (08) : 1300 - +
  • [42] Associations between cutaneous and noncutaneous adverse events among patients treated with immune checkpoint inhibitors
    Eversman, A.
    Thang, C. J.
    Garate, D.
    Gulati, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S155 - S155
  • [43] Patterns of adverse reactions for immune checkpoint inhibitors in cancer patients with central nervous system metastases
    Gu, T.
    Yang, H.
    Shen, J.
    Lin, A.
    Zhang, J.
    Luo, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S645 - S645
  • [44] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [45] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [46] Conditional immune adverse event rate in urothelial and renal cell carcinoma patients treated with immune checkpoint inhibitors
    Nuzzo, Pier Vitale
    Pond, Gregory Russell
    Abou Alaiwi, Sarah
    Nassar, Amin
    Flippot, Ronan
    Curran, Catherine
    Kilbridge, Kerry L.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Harshman, Lauren Christine
    Choueiri, Toni K.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [48] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [49] Musculoskeletal immune-related adverse events in 927 patients treated with immune checkpoint inhibitors for solid cancer
    Melia, Angelique
    Fockens, Emilie
    Sfumato, Patrick
    Zemmour, Christophe
    Madroszyk, Anne
    Lafforgue, Pierre
    Pham, Thao
    JOINT BONE SPINE, 2023, 90 (01)
  • [50] PHYSICIAN AWARENESS OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Araujo, F.
    Fonseca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1777 - 1778
12345